Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

While some folks prefer high-tech wallets with RFID-blocking technology, the majority of people prefer a simple, well-designed leather wallet ... body and elastic straps that expand to hold ...

"What are the 100 best movies of all time?" It's a hell of a question to ask, and an even harder one to answer — even for the team here at Empire, the world's biggest and best-loved movie magazine.

Warner Bros. Discovery Inc. Series A $8.07-1.09-11.90% ...